New EU Filings Include Incyte’s Povorcitinib & Sanofi’s SP0087, US Next In Line

 
• By Neena Brizmohun
  
Hidradenitis Suppurativa Word On Cubes
Incyte has filed an EU marketing application for its oral drug for hidradenitis suppurativa (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from EU CHMP

More from Pink Sheet